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Abstract
Background: A common challenge to the study of several infectious diseases consists in combining limited cross-sectional
survey data, collected with a more sensitive detection method, with a more extensive (but biased) syndromic sentinel
surveillance data, collected with a less sensitive method. Our article describes a novel modeling framework that overcomes
this challenge, resulting in enhanced understanding of malaria in the Western Brazilian Amazon.
Methodology/Principal Findings: A cohort of 486 individuals was monitored using four cross-sectional surveys, where all
participants were sampled regardless of symptoms (aggressive-active case detection), resulting in 1,383 microscopy and
1,400 polymerase chain reaction tests. Data on the same individuals were also obtained from the local surveillance facility
(i.e., passive and active case detection), totaling 1,694 microscopy tests. Our model accommodates these multiple pathogen
and case detection methods. This model is shown to outperform logistic regression in terms of interpretability of its
parameters, ability to recover the true parameter values, and predictive performance. We reveal that the main infection
determinant was the extent of forest, particularly during the rainy season and in close proximity to water bodies, and
participation on forest activities. We find that time residing in Acrelandia (as a proxy for past malaria exposure) decreases
infection risk but surprisingly increases the likelihood of reporting symptoms once infected, possibly because non-naı ¨ve
settlers are only susceptible to more virulent Plasmodium strains. We suggest that the search for asymptomatic carriers
should focus on those at greater risk of being infected but lower risk of reporting symptoms once infected.
Conclusions/Significance: The modeling framework presented here combines cross-sectional survey data and syndromic
sentinel surveillance data to shed light on several aspects of malaria that are critical for public health policy. This framework
can be adapted to enhance inference on infectious diseases whenever asymptomatic carriers are important and multiple
datasets are available.
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Introduction
Extensive syndromic sentinel surveillance data are often
routinely collected by public health agencies. However, estimates
of disease prevalence based on these data are known to be biased
because only symptomatic individuals are sampled [1,2]. Further-
more, because of the sentinel surveillance network extent, cheaper
and less sensitive diagnostic methods are typically employed.
Researchers also collect data to study infectious disease risk factors
and asymptomatic pathogen carriers, but using cross-sectional
surveys and more expensive and sensitive diagnostic methods.
These data, however, are often geographically and temporally
limited and thus are not as abundant as sentinel surveillance data.
Robust inference on disease prevalence and risk factors would
ideally combine these datasets because they clearly complement
each other; unfortunately, standard statistical tools are not well
suited for this task. We describe here a novel statistical model that
coherently combines these disparate datasets, allowing for
enhanced inference on infectious diseases.
Our study focuses on malaria. Malaria is responsible for ,3%
of the total global disease burden [3], affecting approximately half
of the world’s population [4] and significantly hindering economic
and social development of tropical countries [5]. Despite its public
health relevance and recent increased attention to malaria
research and control [6], malaria risk factors remain difficult to
evaluate, due both to the idiosyncrasies of how data are collected
(as detailed below) and the fact that not all infected individuals are
symptomatic. Our approach addresses these challenges, providing
sharper inference on Plasmodium infection risk factors, factors
determining symptom status given infection, and overall infection
and disease prevalence. We first describe the statistical model, then
we compare its performance against standard logistic regression
using simulated and real data, and finally we apply it to a large
malaria dataset collected in the Western Brazilian Amazon.
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27462In Brasil, malaria cases are concentrated in the Amazon region
[7], resulting in substantial morbidity [8,9]. Similar to other
countries (e.g., India, [10]), the malaria surveillance data from the
Brazilian government consist of microscopy results from predom-
inantly symptomatic individuals, sampled through active and
passive case detection (ACD and PCD, respectively). ACD data
are obtained by health agents during home visits to symptomatic
individuals whereas PCD data come from health facilities, visited
by individuals who believe they have malaria [11]. Inherent biases
in both datasets make it difficult to determine overall malaria
prevalence and the factors that influence it [1,12]. Aggressive
active case detection (AACD) has been proposed as an alternative
surveillance technique, consisting of cross-sectional surveys where
all individuals are sampled, regardless of symptom status [11].
AACD data can be used to estimate infection prevalence and its
determinants and the size of the reservoir represented by
asymptomatic Plasmodium carriers [12–14]. Drawbacks of AACD
include high costs and the often low acceptability from the
population [12,14], which often limits AACD data to a short time-
frame and a small geographical area. As a consequence, AACD
data might not be as well suited as ACD/PCD data in determining
the effect of covariates that change substantially in time and/or
space (e.g., precipitation and presence of wetlands).
Imperfect Plasmodium detection is a concern for all surveillance
methods. The Brazilian Health Ministry primarily makes use of
microscopy of thick blood smears, because it is relatively
inexpensive and straight-forward [15]. However, microscopy has
limited ability to detect the pathogen when parasitemia is low [16–
18]. In research settings, Polymerase Chain Reaction (PCR) has
been extensively used as the standard against which the sensitivity
and specificity of other detection methods (e.g., microscopy and
rapid diagnostic tests) are evaluated. Unfortunately, PCR data is
often not available due to costs and expertise required for the
procedure [19,20].
How does one integrate the less biased but more limited dataset
(e.g., data from AACD) with a more extensive, time continuous
and biased dataset (e.g., data from ACD/PCD)? Furthermore,
how can the more sensitive but limited PCR dataset be used jointly
with the less sensitive but more extensive microscopy dataset?
Logistic regression is the most common statistical tool used to
analyze individual-level disease data. However, logistic regression
does not correct for the biases in the ACD/PCD dataset, even if
dummy covariates are added to represent differences in how
individuals were sampled (e.g., AACD, ACD, and PCD). It also
does not accommodate detection error rates for the different
Plasmodium detection methods. In recognition of these problems,
analysis might focus on the most sensitive pathogen detection
method (i.e., PCR) and less biased case detection method (i.e.,
AACD), with the drawback of ignoring considerable information
contained in the rest of the data.
Logistic regression also does not allow for important conditional
relationships that determine malaria risk. Malaria researchers
typically assume perfect detection and choose to model either the
probability of being diseased (i.e., pS ~1,I~1 ðÞ ) or the probability
of being infected (i.e., pI ~1 ðÞ ), where S and I stand for symptom
and infection status. These probabilities are related and models can
be developed to combine them in a statistically and biologically
coherent way. Our model factors p Disease ðÞ ~pS ~1,I~1 ðÞ as
pS ~1jI~1 ðÞ pI ~1 ðÞ , allowing us to separately evaluate infection
risk factors (i.e., pI ~1 ðÞ ) from risk factors of symptoms given
infection (i.e., pS ~1jI~1 ðÞ ). This approach can provide inference
on factors that influence the joint distribution of symptom and
infection statuses. For example, we can coherently estimate the
prevalence of asymptomatic carriers, namely pS ~0,I~1 ðÞ ,a n d
the factors that influence it. The limitations of standard statistical
tools prompted us to create a customized method to analyze our
data.
Here, we illustrate how inference on malaria risk factors and
infection/disease prevalence can be improved using a hierarchical
framework based on the joint distribution of symptom and
infections statuses and by properly accommodating the different
pathogen and case detection methods. First, we detail the model.
Then, we compare the performance of this method to that of
typical logistic regressions using simulated and real data. Finally,
we apply this model on a large malaria dataset collected in the
Western Brazilian Amazon and discuss the implication of our
findings.
Methods
Ethics Statement
The study protocol was approved by the Ethical Review Board
of the Institute of Biomedical Sciences of the University of Sa ˜o
Paulo, Brazil (318/2002 and 538/2004) and we obtained written
informed consent from each adult participant and from the parent
or legal guardian of every minor.
Data
Data were collected in a rural settlement area, in a region
known as Ramal Granada (Acrelandia, Acre, Brasil), on 486
individuals that agreed to participate in the study. AACD data
come from four cross-sectional surveys (March/April 2004,
September/October 2004, February/March 2005, and Octo-
ber/November 2006) in which all study participants that were
present at the time of the survey were sampled, regardless of their
symptomatic status. This dataset contained a total of 1383
microscopy and 1400 PCR malaria tests. Further details on the
area, data collection, and characteristics of this cohort can be
found elsewhere [11,21,22]. We gathered ACD/PCD data by
searching the malaria records at the local health facility. All
malaria records between 2004 and 2007 from the AACD study
participants were entered in a database, resulting in a total of 1694
microscopy tests, with approximately 94% of the individuals
feeling symptomatic when tested.
Model Description
We start by describing some basic conditional probabilities for
our model and their associated assumptions. We then proceed to
detail the likelihood associated with each potential outcome. We
conclude this section with a description of how we fit the model.
Plasmodium detection. We consider data from two
Plasmodium detection methods, namely microscopy and
polymerase chain reaction (PCR). Let Dm
i,t~1 stand for a
positive Plasmodium detection using microscopy for individual i at
time t. Let Ii,t~1 and Si,t~1 stand for being infected and having
malaria symptoms, respectively. Note that Ii,t is a latent variable
because we never directly observe it. Using these definitions, let pD m
i,t~
 
1jSi,t~1,Ii,t~1Þ~a1 and pD m
i,t~1jSi,t~0,Ii,t~1
  
~a0 be the
microscopy sensitivity given that Si,t~1 and Si,t~0, respectively.
We allow sensitivity to depend on symptom status because it has
beenshown that low-gradeinfections(i.e., lowdensity of parasites in
the blood) are associated with asymptomatic cases and failure to
detect them with microscopy [16–18,23]. Furthermore, let
pD m
i,t~0jIi,t~0
  
~1 be the microscopy specificity. We set the
specificity of the microscopy to one because it is virtually impossible
for an experienced microscopist to identify malaria pathogens on a
blood sample from an uninfected patient, regardless of the
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communication; [17]).
In relation to PCR, let D
pcr
i,t ~1 stand for a positive Plasmodium
detection using PCR for individual i at time t. Let the PCR
sensitivity and specificity be denoted by pD
pcr
i,t ~1jIi,t~1
  
~d and
pD
pcr
i,t ~0jIi,t~0
  
~p, respectively. Errors in amplification or
contamination of the sample can produce both false-positives and
false-negatives [17]. From prior knowledge, we know that the
sensitivity of PCR is greater than that of microscopy and that
microscopy sensitivity is probably greater when the individual is
symptomatic than when not symptomatic (i.e., dwa1wa0) [20].
Finally, we assume that PCR sensitivity and specificity are not
influenced by microscopy detection and symptomatic status of the
individual, given infection status. The assumption of conditional
independence between PCR and microscopy results seems reasonable
because detections are based on fundamentally different biological
processes [24,25]. We adopted uniform priors for the sensitivity and
specificity of PCR, where the limits were based on earlier reports on
PCR error rates [26,27]. More specifically, the joint prior adopted for
these detection parameters was a uniform distribution in the set
d,a1,a0 ðÞ : 0va0va1vd,max 0:7,a1 ðÞ vdv1 fg .
Infection risk. We are primarily interested in the probability
that individual i at time t is infected with Plasmodium (i.e., pI i,t~1 ðÞ )
and the associated risk factors. We assume that this probability is
given by
pI i,t~1 ðÞ ~
1
1ze
{ Xi,tbzQizqhi ½ 
  
where Xi,t is the design vector and b is the vector with the
corresponding parameters. The design vector Xi,t contains
potential risk factors. For our case study using data from the
Western Brazilian Amazon, these covariates were gender,
educational level, age, time in Acrelandia (as a proxy for past
exposure to malaria), if participates on extractivism activities, if
hunts or fishes, if works as chain sawyer, if shares the house with
somebody that had a positive malaria diagnosis in the past 30
days, surface water area, forest area, deforestation rate,
precipitation, and a drought index. These covariates are detailed
in Appendix S1. Individual and household-level random effects
are denoted by Qi and qhi ½ , respectively, where h[i] indexes the
household where the i
th person resides. These random effects
were modeled as Qi~
N 0,s2
ind
  
and qhi ½ ~
N 0,s2
h
  
,w h e r es2
ind
and s2
h are the individual and household-level random effect
variances, respectively.
Symptomatic status. We assume that the probability of
being symptomatic given that the person is infected is given by
pS i,t~1jIi,t~1 ðÞ ~
1
1ze
{Yi,tc
where c is a vector of parameters to be estimated and Yi,t is the
design vector. We assume that the covariates most likely to
influence this probability are variables related to the individual’s
immune system and not variables related to present exposure to
vectors. Thus, for our Western Brazilian Amazon case study, the
covariates in Yi,t were age, gender, and time in Acrelandia (as a
proxy for past malaria exposure). Finally, we assumed that the
probability of having symptoms despite not being infected
pS i,t~1jIi,t~0 ðÞ was a constant parameter to be estimated.
Likelihood. The definitions above are the basis for the
hierarchical model that we built (depicted in Fig. 1), borrowing
some ideas from Clark & Hersh [28]. These definitions and model
structure allow us to describe the likelihoods of all the possible
outcomes in AACD (Table S1). For the ACD and PCD datasets,
we start by noting that pI jACD ðÞ wpI ðÞand pI jPCD ðÞ wpI ðÞ ,
because ACD and PCD focuses mostly on symptomatic
individuals. Therefore, we can assume that knowing whether the
person was sampled in ACD or PCD does not bring any additional
information about the risk of being infected if we condition on
symptomatic status. More formally, we assume that
pI jS,ACD ðÞ ~pI jS ðÞ and pI jS,PCD ðÞ ~pI jS ðÞ . Based on these
assumptions, it can be shown that the likelihood for each outcome
will be similar to those for AACD with the exception that it will
have a correction term of the form
p ACDjS ðÞ
p ACD ðÞ
or
p PCDjS ðÞ
p PCD ðÞ
.
Here, p ACDjS ðÞ and p PCDjS ðÞ are the conditional probability
that an individual with symptom status S is sampled through ACD
or PCD, respectively, and p ACD ðÞ and p PCD ðÞ are the
corresponding marginal probabilities. The likelihood of all the
possible outcomes in ACD and PCD is shown in Table S2. The
detailed derivation of these likelihoods is given in Appendix S2.
An important assumption in our analysis of the ACD/PCD
dataset is that malaria tests (and the symptomatic status at the time
of the test) more than one week apart from each other were
considered to be independent. There were some cases where
symptomatic individuals would choose to be tested multiple times
within a short period of time (,7 days), probably expecting a
positive result or the symptoms to ameliorate. To avoid making
several assumptions regarding the temporal dependencies of
symptoms and test results from these multiple tests, we chose to
retain just the first test and the associated symptomatic status
whenever we detected multiple tests within this short time-frame.
Full model. Let h be all the parameters we will estimate and
let yACD,yPCD and yAACD be the different datasets, where
subscripts denote how individuals were sampled. Assuming
conditional independence given the parameters h, the full model
can be written as
p hjyACD,yPCD,yAACD ðÞ !py ACD,yPCD,yAACDjh ðÞ p h ðÞ
!py ACDjh ðÞ py PCDjh ðÞ py AACDjh ðÞ p h ðÞ
Figure 1. Graphical representation of the proposed model,
illustrating some of the modeled conditional relationships.
doi:10.1371/journal.pone.0027462.g001
Modeling Infectious Diseases Using Multiple Data
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27462where p hjyACD,yPCD,yAACD ðÞ is the posterior distribution of the
parameters to be estimated, py kjh ðÞ is the likelihood of dataset k
(Table S1 and Table S2) and p h ðÞ are the priors. All the estimated
parameters h are listed and described in Table 1, together with
their associated priors.
This model was fitted using a Gibbs sampler. Most parameters
were updated using a Metropolis sampling step and the few
parameters that were updated via a Gibbs sampling step have their
full conditional distributions described in Appendix S3. In total,
150,000 iterations were run and the initial 20,000 iterations were
discarded as burn-in. Convergence was assessed using trace-plots
of the parameters.
Model Performance
We compare the proposed model with standard logistic
regressions, both with and without individual and household level
random effects. Let D~1 be a positive Plasmodium detection, either
from microscopy, PCR or both. The response variable for these
logistic regressions were proxies for a) disease: a person having
symptoms and a positive detection (i.e., D~1,S~1); and b)
infection: a person having a positive detection (i.e., D~1)
(Table 2). To mimic how researchers would typically use these
multiple datasets (yACD,yPCD and yAACD), we merged the three
datasets into a single one and added two dummy covariates in the
logistic regressions to allow for differences between datasets.
These different statistical methodologies were compared using
both simulated and real data. Simulated data were used to
compare the different methods in relation to how well they
retrieved the true parameters influencing infection probability. To
evaluate the importance of combining these multiple datasets, we
further compared how inference from the proposed model would
change if fitted only to the PCR dataset versus all datasets. Details
of how the simulated data were generated are given in Appendix
S4, Table S3, and in Table S4. We also compared how well each
model predicted the real data, using a 10-fold cross validation.
This validation exercise consisted in fitting these models to 90% of
Table 1. List of all the estimated parameters and the associated priors.
Parameter Description Prior
a1 Microscopy sensitivity given S=1
uniform in the set
f a0,a1,d ðÞ : 0va0va1vd,
max 0:7,a1 ðÞ vdv1g
a0 Microscopy sensitivity given S=0
d PCR sensitivity
p PCR specificity Unif(0.97,1)
b Covariates of infection risk factors Unif(210,10)
Qi Individual level random effects N 0,s2
ind
  
qh½i  Household level random effects N 0,s2
h
  
sind Standard deviation of the individual-level random effects Unif(0,100)
sh Standard deviation of the household-level random effects Unif(0,100)
c Covariates of risk factors of symptoms given infection Unif(210,10)
pS ~1jI~0 ðÞ Probability of symptoms given no infection Unif(0,1)
pS ~1jI~0 ðÞ Probability of being sampled through PCD given no symptoms
uniform in the set
f p PCDjS~0 ðÞ ,p ACDjS~0 ðÞ ðÞ :
p ACDjS~0 ðÞ zp PCDjS~0 ðÞ v1g
p ACDjS~0 ðÞ Probability of being sampled through ACD given no symptoms
p PCDjS~0 ðÞ Probability of being sampled through PCD given symptoms
uniform in the set
f p PCDjS~1 ðÞ ,p ACDjS~1 ðÞ ðÞ :
p ACDjS~1 ðÞ zp PCDjS~1 ðÞ v1g
p PCDjS~1 ðÞ Probability of being sampled through ACD given symptoms
doi:10.1371/journal.pone.0027462.t001
Table 2. Description of all the modeling approaches employed in the simulation and validation exercises.
Models Outcome Description Random effects
1 D~1,S~1 ðÞ , D~1,S~0 ðÞ , D~0,S~1 ðÞ , D~0,S~0 ðÞ proposed model Yes
2{ Disease D~1,S~1 ðÞ logistic regression No
3{ Infection D~1 ðÞ logistic regression No
4{{ Disease D~1,S~1 ðÞ logistic regression Yes
5{{ Infection D~1 ðÞ logistic regression Yes
No covariate Disease D~1,S~1 ðÞ Infection D~1 ðÞ Uses the proportion of D~1,S~1 ðÞ and D~1 ðÞ in the training
dataset to predict outcomes for the validation dataset
No
{these models were fit using the ‘glm’ function in R.
{{these models were fit using the ‘lmer’ function in R.
doi:10.1371/journal.pone.0027462.t002
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10%. This was done ten times with different portions of the data
retained for validation at each time. Each method predicted which
individuals had a positive test result (D~1) and which individuals
had a positive test result and were symptomatic (D~1,S~1). We
summarized this information as a) the proportion of individuals
correctly predicted as D~1 or D~0; and b) the proportion of
individuals correctly predicted as D~1,S~1 or not D~1,S~1.
For this validation exercise, we also evaluated the predictive ability
of the chosen covariates by adding the prediction results from a
model that simply used the proportion of individuals with D~1
(or D~1,S~1) in the training dataset. All statistical procedures
and graphics were performed in R [29].
Results
Model performance
Our results using simulated data reveal that the 95% confidence
intervals from the logistic regressions, both with and without
random effects, were typically narrower than the 95% credible
intervals from the proposed model (Fig. 2), often missing the true
regression parameters, even when these effects were large. In
contrast to these results, the 95% credible interval generated by
the proposed model fitted to all datasets always included the true
regression parameters. One parameter of particular importance is
the intercept as it reveals the infection prevalence for individuals
with mean covariate values. Our results show that all logistic
regressions grossly overestimated this parameter. The simulated
data also revealed that fitting the proposed model to all datasets
(microscopy and PCR results from the ACD, PCD, and AACD
datasets) resulted in sharper inference, both in terms of smaller
bias and uncertainty, when compared to results from the proposed
model fitted just to PCR results (black circle vs. black triangle,
Fig. 2). This improved inference arises not only because of the
larger sample size but also because the ACD and PCD datasets are
more time continuous, resulting in greater variability for several
covariates.
An important concern related to the proposed model is that it
might be over-fitting the data, given that it includes almost twice as
many parameters as the logistic regressions (30 vs. 17, respectively,
Figure 2. Comparison of models using simulated data. The true values of the infection risk factor parameters are depicted in horizontal black
dashed lines. Logistic regression models with disease (models 2 and 4) and infection (models 3 and 5) as response variables are depicted in red and
blue, respectively. Models with and without random effects are depicted with continuous and dashed vertical lines, respectively. Models 2–5 were
fitted to all datasets. Model 1 was fitted twice, once for just the PCR dataset (black triangle) and once for all datasets (black circle). Details of these
models are given in Table 2.
doi:10.1371/journal.pone.0027462.g002
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resulting in poor out-of-sample predictive ability. However, our
validation results using the real data show that the proposed model
had a similar or better predictive ability when compared to the
logistic regression model with random effects (Fig. 3). Interestingly,
even the model without any covariates had a good predictive
ability, sometimes yielding equivalent or better predictions than
the logistic models, with or without random effects. In contrast, the
proposed model always yielded better predictions than the model
without any covariates. Furthermore, the proposed model is
capable of generating all predictions depicted in Fig. 3 whereas
distinct logistic regressions were fit to predict these different
outcomes.
Findings from the Western Brazilian Amazon region
We estimated that the infection prevalence for the cohort we
studied was approximately 0.13 (95% credible interval (CI) 0.10–
0.16). Malaria prevalence was considerably lower (0.04, 95% CI
0.03–0.06) because not all individuals exhibit symptoms. From the
pool of infected individuals, more than half will typically be
asymptomatic (0.63, 95% CI 0.53–0.72) but the overall prevalence
of asymptomatic carriers is low (0.08, 95% CI 0.06–0.12). We can
compare these model-based estimates with estimates calculated
directly from the data, if we assume that all individuals with a
positive (or negative) detection result are infected (or not infected).
Similar, but not identical, results were obtained using only PCR
data (Fig. 4). On the other hand, considerably different summary
statistics were obtained using microscopy, either from AACD or
from the PCD/ACD datasets. These differences arise because
microscopy is known to have limited ability to detect individuals
with low parasitemia, which tend to be asymptomatic individuals,
and because the PCD/ACD datasets include predominantly
symptomatic individuals. One option would be to analyze just
the PCR dataset collected with the AACD method, ignoring
malaria risk information from the other datasets. However, as we
showed with the simulated data and as suggested elsewhere [30],
Figure 3. Comparison of models by out-of-sample prediction. These figures show the proportion of individuals correctly classified by each
model. Numbers on the left refer to the different validation datasets. Logistic regression models with disease (models 2 and 4) and infection (models
3 and 5) as response variables are depicted in red and blue, respectively. Models with and without random effects are depicted with continuous and
dashed lines, respectively. Details of these models are given in Table 2.
doi:10.1371/journal.pone.0027462.g003
Figure 4. Comparison of summary statistics calculated directly from the data and generated by the proposed model. The summary
statistics are infection (i.e., pI ~1 ðÞ ) and malaria prevalence (i.e., pI ~1,S~1 ðÞ ), proportion of asymptomatic individuals among the pool of infected
individuals (i.e., pS ~0jI~1 ðÞ ) and overall proportion of asymptomatic carriers in the population (i.e., pS ~0,I~1 ðÞ ). Estimates from the proposed
model are depicted in black. Estimates calculated directly from the data are depicted in red (PCR data), green (microscopy results from AACD), and
blue (microscopy results from ACD and PCD). Vertical lines depict 95% credible intervals for model 1 and approximate 95% confidence intervals for
the other estimates, calculated as ^ p p+2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
^ p p 1{^ p p ðÞ
n
r
.
doi:10.1371/journal.pone.0027462.g004
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used if the model is able to adequately accommodate the inherent
differences among datasets. Thus, we exploit the information on
infection/disease prevalence and malaria risk factors from all
datasets.
The clearest infection risk factor was forest extent surrounding
the subject’s house (Table 3, Fig. 5; the marginal posterior
distributions for all the estimated parameters are provided in
Figure S1 and Figure S2). The effect of forest extent was further
exacerbated by proximity to larger water bodies, particularly
during the wet season. Furthermore, men (probably as a result of
spending more time in the forest than women) and those
participating in forest related activities (e.g., extractivism, hunting
or fishing) were more likely to be infected (Table 3, Fig. 5). These
risk factors consistently suggest that these degraded forests are
prime breeding habitat for the vector. On the other hand, annual
deforestation rates and working as a chain sawyer were not
important risk factors. We hypothesize that the extensive use of fire
for land clearing during the dry season might be responsible for
this pattern. We also expected increased infection risk if the person
co-inhabited a house with somebody diagnosed with malaria
within the past 30 days but this was not the case, probably because
infectious individuals might be diagnosed after (instead of before)
the focal person is tested for malaria. Unfortunately, these past and
future dependencies cannot currently be included in the model.
There is some evidence that time living in Acrelandia, as a
proxy for past malaria exposure, reduces the risk of being infected
(Table 3, Fig. 5). This result suggests that non-naı ¨ve settlers
acquire parasitological immunity and/or considerable knowledge
on how to reduce one’s exposure to infection. However, our results
also suggest that this same factor increases the probability of
feeling symptoms once infected (Table 3). One possible explana-
tion is that non-naı ¨ve settlers are only susceptible to the more
virulent Plasmodium strains.
Asymptomatic Plasmodium carriers pose a considerable public
health challenge. Our results suggest ways to strategically identify
Table 3. Summary statistics for the estimated parameters.
Class Parameter Percentile
2.50% 50% 97.50%
Infection risk factors (odds-ratio) Intercept 0.076 0.120 0.187
Gender 0.430 0.657 0.986
Age 0.878 1.096 1.345
Education 0.841 1.008 1.215
Time in Acrelandia 0.596 0.763 0.956
Chain Sawyer 0.009 0.363 3.235
Extractivism 1.057 1.782 2.994
Hunting/Fishing 1.140 1.647 2.386
Co-inhabits D
m=1 0.559 0.917 1.490
Co-inhabits D
pcr=1 0.403 0.824 1.691
Water area 0.667 0.800 0.957
Forest area 1.430 1.923 2.569
Annual defor. 0.719 0.909 1.139
Monthly precip. 0.810 0.975 1.175
Drought index 0.770 0.932 1.145
Precip. x forest 1.004 1.183 1.405
Drought x forest 0.803 0.958 1.155
Water x forest 1.048 1.404 1.899
Symptoms given infection risk factors (odds-ratio) Intercept 0.411 0.641 1.076
Age 0.645 0.884 1.240
Gender 0.451 0.859 1.704
Time in Acrelandia 1.043 1.481 2.268
Other parameters (probabilities) Mic. sensit.|S=0 0.053 0.101 0.175
Mic. sensit.|S=1 0.249 0.293 0.348
PCR Sensitivity 0.708 0.796 0.901
PCR Specificity 0.970 0.974 0.990
p(S=1|I=0) 0.015 0.023 0.034
p(ACD|S=1) 0.075 0.380 0.770
p(ACD|S=0) 0.000 0.002 0.005
p(PCD|S=1) 0.084 0.391 0.775
p(PCD|S=0) 0.000 0.001 0.002
doi:10.1371/journal.pone.0027462.t003
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symptoms (as in AACD) might be useful, a more efficient strategy
would be to sample individuals at high risk of infection but low
probability of feeling symptoms given infection. In other words, we
maximize pS ~0,I~1 ðÞ ~pS ~0jI~1 ðÞ pI ~1 ðÞ by maximizing
the individual components pS ~0jI~1 ðÞ and pI ~1 ðÞ . For
instance, if we estimate the probability of being an asymptomatic
Plasmodium carrier as a function of time in Acrelandia and forest
extent, it becomes clear that we should preferentially sample
individuals that are new to the area (thus with high pS ~0jI~1 ðÞ )
on highly forested areas with abundant surface water (thus with
high pI ~1 ðÞ ) (Fig. 6).
The estimated parameters can be jointly used to make coherent
predictions, relying on information from all datasets. For example,
a predicted infection risk surface can be created using information
on surface water and forest area (infection prevalence map in
Fig. 7). These results can be extrapolated to a larger geographical
region using remote sensing imagery, revealing substantial spatial
heterogeneity in infection prevalence attributable to the river that
crosses the upper part of the region and the large forest blocks
away from the roads (extrapolated infection prevalence map in
Fig. 7). These maps also highlight the striking differences in
infection prevalence due to precipitation, a result greatly
corroborated by recent entomological surveys conducted at the
same site [31]. Besides infection risk surfaces, asymptomatic
carrier risk and malaria burden surfaces can also be created, using
household information on how long people have been living in
Acrelandia (asymptomatic carrier and malaria prevalence maps in
Fig. 7). Despite similarities, the asymptomatic carrier prevalence
surface indicates that these carriers are more likely to be found in
the northern part of our study area whereas infected symptomatic
individuals can also be found in the central region of our study
area.
As expected, we find strong influence of priors on the estimation
of the PCR error rates (Fig. S2), suggesting that there was not
enough information on our dataset to estimate all these parameters
jointly. Microscopy sensitivity, on the other hand, was well
estimated to be approximately 0.3 and 0.1, almost a three-fold
difference for symptomatic and asymptomatic individuals, respec-
tively (Table 3). Nevertheless, even for symptomatic individuals,
Figure 5. Probability of infection pI ~ ~1 ðÞ as a function of the most important covariates. The probability of infection was calculated with
the other covariates fixed at their mean value. CI stands for credible interval. Lower right panel shows the independent effect of being a woman
(‘Women’), being a man (‘Men’), participating on extractivism activities (‘Extract.’), and participating on hunting or fishing activities (‘Hunt/Fish’). The
summed effect of being a man, partipating on extractivism and hunting/fishing activities is also shown (‘M,E,HF’).
doi:10.1371/journal.pone.0027462.g005
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be derived from these error rate estimates. For example, sampling
predominantly symptomatic individuals(asis usually done inACD/
PCD) is sensible given that the probability of being infected
pI ~1 ðÞ ~0:13 increases dramatically if the person is symptomatic
pI ~1jS~1 ðÞ ~0:63. However, the challenge of using microscopy
as the only method to monitor infection and disease prevalence is
evident if we compare our knowledge of infection probability for
symptomatic individuals before and after obtaining a negative
microscopy result (pI ~1jS~1 ðÞ ~0:63 and pI ~1jS~1, ð
Dm~0Þ~0:55, respectively), indicating very little gain of informa-
tion when microscopy yields a negative result. This finding suggests
that close monitoring of individuals that are symptomatic but that
have recently obtained a negative microscopy result might be
warranted. On the other hand, a positive microscopy detection is
very informative since pI ~1jDm~1 ðÞ ~1. PCR results, regardless
if positive or negative, were also informative since pI ~1 ðÞ ~0:13
but pI ~1jDpcr~1 ðÞ ~0:76 and pI ~1jDpcr~0 ðÞ ~0:03.
Discussion
Large spatial-scale patterns regarding malaria typically involves
syndromic surveillance data (e.g., [32,33]), despite limited
microscopy sensitivity and the biased nature of these data. On
the other hand, more reliable infection and disease prevalence
estimates are often spatially and temporally restricted, relying
almost exclusively on PCR data [13,22,34–36]. The proposed
model uses information from both datasets to improve the
estimates of infection and disease prevalence at our research site,
which is then extrapolated to a larger area. Alternatively, we can
infer large spatial-scale patterns of Plasmodium infection prevalence
using the syndromic surveillance data after adjusting for the
inherent biases in this dataset. This adjustment is only possible
with the parameters estimated here and is part of our ongoing
research.
Our results identifythe important role of forests and forestrelated
activities in Plasmodium infection risk, particularly during the rainy
season and in close proximity to large water bodies (Fig. 5).
Unfortunately, the data do not contain more information regarding
these forests (e.g., level of forest degradation) and thus we cannot
determine which characteristic of these forests are important
infection risk factors. These results corroborate the findings of
othersthat proximitytotheforestenhancesinfectionrisk[22,31,37–
39]butwedonotfindsupport fortheidea thatdeforestationactivity
per se [33] or the lack of forest [40,41] significantly increase infection
risk. Our results also suggest that one of the factors most amenable
to public policy is the participation in forest related activities (e.g.,
extractivism, hunting and fishing activities). Hunting and fishing
activities are particularly popular, with nearly two thirds of the
individuals in our cohort reporting that they engage in these
activities. Educational campaigns might be effective in raising
awareness about how participation in these activities affects one’s
health and the health of their family and community, particularly
for those individuals more likely to exhibit symptoms given infection
(i.e., non-naı ¨ve settlers).
Figure 6. Probability of sampling an asymptomatic Plasmodium carrier (i.e., pS ~ ~0,I~ ~1 ðÞ ). The probability of sampling an asymptomatic
Plasmodium carrier is shown as a function of time in Acrelandia and proportion of forest area in places with abundant surface water.
doi:10.1371/journal.pone.0027462.g006
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depends on age (as a proxy for past malaria exposure), with severe
malaria being relatively common for young children, and older
cohorts having progressively less cases of severe malaria and
proportionally more cases of mild malaria and asymptomatic
infection [23,42]. This descriptions refers to people exposed to
malaria since birth in holoendemic countries, but it is much more
complex (and less well understood) in areas with lower levels of
exposure and where mild malaria predominates [23]. In these
latter settings, previous studies have suggested that past exposure
to malaria can decrease clinical malaria risk in rural settlers [22]
and provide both anti-parasite and anti-disease immunity in
traditional riverine populations [13,34]. Our results suggest that
anti-parasite immunity arises even in rural settlers. However,
unlike previous studies, we find evidence that it also increases the
probability of feeling symptoms once infected. We hypothesize
that more experienced settlers are susceptible only to more virulent
Plasmodium strains. Further studies are clearly needed to determine
if this hypothesis is correct.
Joint models or analyzes, like ours, are models that simulta-
neously make inference on multiple outcomes (e.g., detection and
symptom status), even allowing one outcome to influence the others
(e.g., symptom status affecting detection). These models have
recently become very popular in the medical statistics literature
because more information and interpretability can be gained when
compared to performing separate analysis of the different outcomes
(e.g., [43,44]). Another active research area in statistics focuses on
the use of multiple pathogen detection methods to determineoverall
disease prevalence and sensitivity/specificity of these detection
methods [24,45–49]. A recent malaria-specific example can be
found in Speybroeck et al. [50]. Our model builds on both of these
trendsbyevaluatingtherisk factorsofinfectionandsymptomsgiven
infection using data from multiple case and pathogen detection
methods.Ourresults using simulatedand real data revealed that the
proposed model yields better inference on risk factors and disease/
infection prevalence without over-fitting the data. To our
knowledge, most of the epidemiological research regarding malaria
has focused on infection risk factors. However, unlike standard
Figure 7. Spatial distribution of infection, asymptomatic carrier, and malaria prevalences. From left to right, maps depict interpolated
surfaces of predicted infection prevalence (i.e., pI ~1 ðÞ ), asymptomatic carrier prevalence (i.e., pS ~0,I~1 ðÞ )), and malaria prevalence (i.e.,
pS ~1,I~1 ðÞ ), all for the studied area, and an extrapolated surface of infection prevalence. Upper and lower maps are the prevalence surfaces for the
rainy and dry seasons, respectively. Interpolation was done using an inverse distance weighted algorithm.
doi:10.1371/journal.pone.0027462.g007
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several other important parameters, such as detection error rates
and riskfactors associated withsymptoms given infection.The latter
is critical to advance our understanding of malaria burden and
asymptomatic carriers. A direct result of this coherent inference is
the identification of the need for better monitoring strategies
regarding symptomatic individuals with negative microscopy results
and how to sample more effectively potential asymptomatic
Plasmodium carriers (Fig. 6). Finally, predicted surfaces of infection
risk, asymptomatic carrier risk, and malaria burden allow for
optimal spatial allocation of resources and malaria control activities.
One of the critical assumptions in our analysis was that data
from ACD/PCD only differ from the AACD data by the
unusually high proportion of symptomatic individuals. Although
this is clearly a key factor, other characteristics of the individuals
sampled in ACD/PCD might also be important, such as the
distance of their house to the health facility. Also, our model
clearly depends on having individual level data on both positive
and negative microscopy tests. Unfortunately, individual level data
from negative microscopy tests are typically discarded, both by the
Brazilian Ministry of Health and malaria researchers, hampering
future analysis of these rich datasets.
We modeled symptomatic status as a binary variable despite the
fact that there is considerable variation in the type and intensity of
symptoms one may exhibit [11]. Future work might allow for
multinomial or continuous symptomatic status. Evidently, this
would only be productive if this symptomatic status score was
collected routinely in AACD and ACD/PCD. Another variable
not included in the model is parasitemia. Precise and accurate
estimates of this variable can be challenging to obtain [51].
Although new quantitative PCR methods can potentially over-
come this problem, dramatic fluctuations in parasite density occur
in the same individual within a short time period [18]. Therefore,
the inclusion of parasitemia into an analysis like ours remains an
important challenge. Furthermore, there is no way to distinguish
new Plasmodium infections from recrudescence and relapses, even
using modern genotyping technology, given that an individual
might be initially infected by multiple strains and/or re-infected by
the same common strain [52,53]. Thus, what we have called
infection risk factors actually refers to the risk factors of having a
relapse, a recrudescence, and/or a new infection. Finally, because
P. vivax and P. falciparum are particularly prevalent in the region, it
would be interesting to evaluate if the probability of feeling
symptoms given infection or the infection risk factors differ among
these species. This remains an important research topic.
Using malaria in the Western Brazilian Amazon as a case study,
we have shown that the modeling framework presented here can
exploit information from multiple datasets to shed light on several
aspects of an infectious disease (e.g., infection risk factors, risk
factors associated with symptoms given infection, detection error
rates) that are critical for its monitoring and control (e.g.,
indicating how to efficiently search for asymptomatic carriers
and which symptomatic individuals should be closely monitored).
While standard logistic regressions are undoubtedly important
tools, these statistical models are not well suited to integrate
multiple datasets. We believe that the Bayesian modeling
framework described here fundamentally enhances our ability to
overcome this challenge, being broadly applicable to other settings
and diseases whenever asymptomatic carriers are an important
public health concern and multiple datasets are available.
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